Appeal No.2001-1715 Application No. 08/730,892 DISCUSSION We have carefully reviewed the claims, specification and applied prior art, including all of the arguments advanced by both the Examiner in the Answer and Appellants in the Brief and Reply Brief, in support of their respective positions. This review leads us to conclude that the Examiner’s § 103 rejection is not well founded. See In re Oetiker, 977 F.2d 1443, 1445, 24 USPQ2d 1443, 1444 (Fed. Cir. 1992); In re Piasecki, 745 F.2d 1468, 1471-1472, 223 USPQ 785, 787-788 (Fed. Cir. 1984). Von der Goltz describes a flow device for use in a hemorrhaging time measuring apparatus. The device is an apparatus that comprises a housing through which the blood to be tested flows under a suction effect. In a preferred embodiment, at least one aperture is provided in a partitioning or separating wall which defines a cavity into which the suction tube projects. The porous member may be permeated and/or coated with collagen. Von der Goltz also discloses that the porous member can be coated with agents that induce thrombocyte aggregation, including adenosine diphosphate (ADP), or a thrombocyte- activating agent phospholipid such as PAF. Von der Goltz does not specify whether the separating wall is coated prior to use or whether the separating wall is embedded with the chemical reagent. The Examiner relies on Przybylowicz to provide motivation to embed the separating wall with chemical reagents. Specifically, the Examiner relies on Przybylowicz for teaching 3Page: Previous 1 2 3 4 5 6 7 NextLast modified: November 3, 2007